AiVita Biomedical Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:AiVita Biomedical Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11060
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AiVita Biomedical Inc (AiVita) is a biotechnology company developing novel stem cell technologies to develop cell-based treatments and healthcare products for the treatment of cancer, vision loss, and skincare formulations. Its lead therapeutic candidate is a patient-specific immunotherapy for the treatment of advanced cancers, glioblastoma and ovarian cancer. The company’s preclinical programs include human stem cells differentiated into sheets of retinal tissue to treat degenerative retinal diseases; and anti-aging skin care technology. AiVita is focused on the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. AiVita Biomedical is headquartered in Irvine, California, the US.

AiVita Biomedical Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AiVita Biomedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
AiVita Biomedical Raises USD15 Million in Series B Financing 10
AiVita Biomedical Raises Additional USD3.5 Million in Venture Financing 11
AiVita Biomedical Raises USD2 Million in Series A Financing 12
Licensing Agreements 13
Caladrius Biosciences Enters into Licensing Agreement with AiVita Biomedical 13
AiVita Biomedical Enters into Licensing Agreement with Caladrius Biosciences 14
AiVita Biomedical Inc – Key Competitors 15
AiVita Biomedical Inc – Key Employees 16
AiVita Biomedical Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
Aug 16, 2018: AIVITA Biomedical appoints chief financial officer and vice president of business development 18
Sep 21, 2017: Renowned Dermatologist Dr. Michael H. Gold Joins AIVITA Scientific Advisory Board 19
May 03, 2017: AIVITA Biomedical names Ed Inal as Chief Operating Officer 20
Government and Public Interest 21
Jul 17, 2018: AIVITA Biomedical receives $1.7 million CIRM Grant to treat Vision loss 21
Sep 19, 2017: AIVITA Biomedical Announces New Discovery with Applications to Regenerative Medicine, Skin Aging and Hair Growth 22
Product News 23
Jun 14, 2018: AIVITA Biomedical Randomizes First Patient in Phase II Ovarian Cancer Trial 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Key Facts 2
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AiVita Biomedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AiVita Biomedical Inc, Deals By Therapy Area, 2012 to YTD 2018 8
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AiVita Biomedical Raises USD15 Million in Series B Financing 10
AiVita Biomedical Raises Additional USD3.5 Million in Venture Financing 11
AiVita Biomedical Raises USD2 Million in Series A Financing 12
Caladrius Biosciences Enters into Licensing Agreement with AiVita Biomedical 13
AiVita Biomedical Enters into Licensing Agreement with Caladrius Biosciences 14
AiVita Biomedical Inc, Key Competitors 15
AiVita Biomedical Inc, Key Employees 16

List of Figures
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AiVita Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[AiVita Biomedical Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Choppies Enterprises Limited (CHOPPIES):企業の財務・戦略的SWOT分析
    Choppies Enterprises Limited (CHOPPIES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Sunnybrook Research Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Sunnybrook Research Institute (SRI) an educational institute that offers medical education and research services. The institute provides undergraduate, postgraduate and doctoral degree programs. It provides research platforms for biological sciences, evaluative clinical sciences and physical …
  • Avita Medical Ltd (AVH):企業の財務・戦略的SWOT分析
    Avita Medical Ltd (AVH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Premier Farnell Ltd:企業の戦略的SWOT分析
    Premier Farnell Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Mitochon Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Mitochon Pharmaceuticals Inc (Mitochon Pharma) is a biotechnology company that develops drugs for neurodegenerative and neuromuscular diseases. The company’s pipeline products include mitochondrial modulators such as MP-101, MP-201 and MP-301. It targets diseases such as batten disease, stro …
  • Feilo Sylvania Europe Ltd:企業の戦略的SWOT分析
    Feilo Sylvania Europe Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • TC Pipelines LP (TCP):石油・ガス:M&Aディール及び事業提携情報
    Summary TC Pipelines LP (TC Pipelines) is an oil and gas company that manages natural gas pipelines and related assets. The company offers development and operation of North American energy infrastructure including natural gas and liquids pipelines, power generation and gas storage facilities. It op …
  • Quidel Corp (QDEL):企業の財務・戦略的SWOT分析
    Quidel Corp (QDEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Harpoon Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Harpoon Therapeutics Inc (Harpoon Therapeutics) is a biotechnology company that offers solutions for immune-oncology diseases. The company provides products portfolio such as of HPN424, prostate specific antigen and harnesses a technology named TriTAC technology. It employs TriTAC technology …
  • Penn Virginia Corporation (PVAC):石油・ガス:M&Aディール及び事業提携情報
    Summary Penn Virginia Corp (Penn Virginia) is an independent oil and gas company. It explores, develops, and produces crude oil, Natural gas liquids (NGL), and natural gas. The company’s operations consist primarily of drilling unconventional horizontal development wells and operating producing well …
  • Spritzer Bhd:企業の戦略・SWOT・財務情報
    Spritzer Bhd - Strategy, SWOT and Corporate Finance Report Summary Spritzer Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • WD-40 Company (WDFC):企業の財務・戦略的SWOT分析
    Summary WD-40 Company (WD-40) is a lubricant distributor. The company develops and markets maintenance products, and homecare and cleaning products. Its products are used in rust and corrosion resistive, penetrates stuck parts, and moisture barriers. WD-40 also provides surface cleaners and automati …
  • Codexis Inc (CDXS)-製薬・医療分野:企業M&A・提携分析
    Summary Codexis Inc (Codexis) is a biotechnology company, which focuses on the development of biocatalysts for commercial scale production of fine chemicals and pharmaceuticals. The company’s product portfolio includes pharmaceutical enzymes and intermediates, active pharmaceutical ingredients (APIs …
  • Bank of Ireland:戦略・SWOT・企業財務分析
    Bank of Ireland - Strategy, SWOT and Corporate Finance Report Summary Bank of Ireland - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Microbion Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Microbion Corp (Microbion) is a clinical stage biopharmaceutical company that develops therapeutic products. The company develops products for the treatment of chronic infections and antibiotic-resistant infections. It develops environmentally responsible solutions to prevent microbial biofi …
  • P. H. Glatfelter Co (GLT):企業の財務・戦略的SWOT分析
    P. H. Glatfelter Co (GLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Airservices Australia:企業の戦略的SWOT分析
    Airservices Australia - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • C&D Technologies Inc:企業の戦略的SWOT分析
    C&D Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • KYORIN Holdings Inc (4569):製薬・医療:M&Aディール及び事業提携情報
    Summary KYORIN Holdings Inc (KYORIN), formerly known as KYORIN Co.,Ltd., is a holding company. Its business activities include controlling, administering and supporting companies, which conduct various businesses by holding the shares of those companies. The company through its subsidiaries carries …
  • Banco Hipotecario SA (BHIP3):企業の財務・戦略的SWOT分析
    Banco Hipotecario SA (BHIP3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆